Examine the data and tweets to deduce if the closing price of $gild will boost or lower at 2017-11-02. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-10-19,-0.1,1.1,-1.3,2.0,2.0,-1.2,-0.2,0.3,0.7,0.8,1.1
2017-10-20,0.9,0.9,-0.9,-0.5,-0.5,-0.8,0.1,0.8,1.0,1.2,1.4
2017-10-23,1.3,1.4,-0.1,-1.3,-1.3,0.6,1.2,1.8,2.1,2.4,2.6
2017-10-24,0.1,0.3,-1.6,-0.1,-0.1,0.6,0.9,1.7,2.0,2.4,2.5
2017-10-25,0.2,0.2,-1.5,-0.3,-0.3,0.9,0.8,1.7,2.0,2.5,2.6
2017-10-26,0.5,2.1,-1.1,-2.5,-2.5,2.5,3.0,3.9,4.4,4.9,5.1
2017-10-27,-2.7,0.2,-5.6,-1.0,-1.0,2.5,3.6,4.5,5.3,5.7,6.0
2017-10-30,0.1,1.2,-1.0,-1.4,-1.4,2.9,4.5,5.5,6.3,6.8,7.2
2017-10-31,1.2,1.9,-0.3,-1.4,-1.4,2.9,5.2,6.2,7.2,7.8,8.3
2017-11-01,-0.2,1.4,-0.8,-0.2,-0.2,1.8,4.7,5.7,6.9,7.5,8.1

2017-10-19: rt AT_USER #nih #nci $gild $nvs #cancer #pharma #biotech |rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg¡­|#nih #
2017-10-20: gilead sciences, inc. $gild given hold rating at maxim group |next thursday is the big earning day, so many big tech companies will report, $googl $amzn $msft $intc $gild $celg, $fslr, etc.|10/20/17 v
2017-10-21: rt AT_USER #earnings $amd $amzn $googl $msft $v $ba $intc $mcd $cat $hal $cmg $stx $lmt $t $has $gm $f $bidu $twtr $gild $celg  |rt AT_USER #earnings $amd $amzn $googl $msft $v $ba $intc $mcd $cat $ha
2017-10-22: bullish swing trade setups for mon, oct 23 include $wfc $baba $schw $gild $qcom  #stocks |gilead sciences $gild is s/t choppy. fpe 11, net margin 42.9%. earnings oct'26th. bullish &gt;90 to 110 by mid
2017-10-23: rt AT_USER how much is hiv cure worth alone $gild /$sgmo |$teva closed at $14.54! what an #allergan nightmare! $agn $amzn $aapl $brk $crm $cmg $dis $exel $f $googl $gild¡­ |ibd's no. 2 group tested as
2017-10-24: $gild $ahgif gilead sciences to report q3 , alternate health corp. projected $75m in revenue for the next 12 months |$gild $ahgif gilead sciences to report q3 , alternate health corp. projected $75m i
2017-10-25: #allergan #botox injector promoting #botox for depression while still unapproved in clinical trials AT_USER $agn¡­ |AT_USER if $gild can pay 12b for $kite, then why not $sgmo?  far more options with z
2017-10-26: rt AT_USER $gild said there will be an update of zuma-1 and zuma-3 at #ash17.|rt AT_USER $bmy says indirect nash markers like liver fat won¡¯t be enough. biopsy will be necessary as an endpoint in pha
2017-10-27: gilead sciences, inc. $gild issues quarterly  earnings results, beats expectations by $0.14 eps |gilead sciences, inc. $gild issues quarterly  earnings results, beats expectations by $0.14 eps |what a
2017-10-28: check this out! $tst $agn $vrx $twtr $ibm $pep $ko $hlf $gild $aapl $amzn $jnj $teva $dis $myl $mrk #allergan $brk¡­ |fyi!  $amzn $aapl $agn $myl $vrx $twtr $mrk $gild $brk $googl $iep $snap $ipxl $ms
2017-10-29: AT_USER AT_USER i do not expect $gild to pick up $blcm - gilead competitors in cart are being extremely¡­ |$gild had good earnings. m/t bullish to $110 and beyond. fpe 10s. nm 44.4%. arguably, the bes
2017-10-30: rt AT_USER today's ex of "know ur lvls" $gild:drew s/r line months ago. here is an old chart that shows it. vs where it failed |commented on  $abbv $glpg $jnj $mrk $nvo $nvs $rhhby $gild|rt AT_USER $g
2017-10-31: rt AT_USER $gild settled -7.5% to $74.96. s/t price structure is a bull flag. m/t hyper bullish &gt;90 to 110, and way beyond. nm 44.4%¡­|$gild settled -7.5% to $74.96. s/t price structure is a bull f
2017-11-01: rt AT_USER #celltherapy #dcvax potential all solid tumors $nwbo is big threat to $mrk $nvs $gild $rhhby $pfe $bmy p3 data will se¡­| review of connor alerts - excellent service for small trading accou
Answer:
Examine the data and tweets to deduce if the closing price of $gild will boost or lower at 2017-11-02. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-10-19,-0.1,1.1,-1.3,2.0,2.0,-1.2,-0.2,0.3,0.7,0.8,1.1
2017-10-20,0.9,0.9,-0.9,-0.5,-0.5,-0.8,0.1,0.8,1.0,1.2,1.4
2017-10-23,1.3,1.4,-0.1,-1.3,-1.3,0.6,1.2,1.8,2.1,2.4,2.6
2017-10-24,0.1,0.3,-1.6,-0.1,-0.1,0.6,0.9,1.7,2.0,2.4,2.5
2017-10-25,0.2,0.2,-1.5,-0.3,-0.3,0.9,0.8,1.7,2.0,2.5,2.6
2017-10-26,0.5,2.1,-1.1,-2.5,-2.5,2.5,3.0,3.9,4.4,4.9,5.1
2017-10-27,-2.7,0.2,-5.6,-1.0,-1.0,2.5,3.6,4.5,5.3,5.7,6.0
2017-10-30,0.1,1.2,-1.0,-1.4,-1.4,2.9,4.5,5.5,6.3,6.8,7.2
2017-10-31,1.2,1.9,-0.3,-1.4,-1.4,2.9,5.2,6.2,7.2,7.8,8.3
2017-11-01,-0.2,1.4,-0.8,-0.2,-0.2,1.8,4.7,5.7,6.9,7.5,8.1

2017-10-19: rt AT_USER #nih #nci $gild $nvs #cancer #pharma #biotech |rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg¡­|#nih #
2017-10-20: gilead sciences, inc. $gild given hold rating at maxim group |next thursday is the big earning day, so many big tech companies will report, $googl $amzn $msft $intc $gild $celg, $fslr, etc.|10/20/17 v
2017-10-21: rt AT_USER #earnings $amd $amzn $googl $msft $v $ba $intc $mcd $cat $hal $cmg $stx $lmt $t $has $gm $f $bidu $twtr $gild $celg  |rt AT_USER #earnings $amd $amzn $googl $msft $v $ba $intc $mcd $cat $ha
2017-10-22: bullish swing trade setups for mon, oct 23 include $wfc $baba $schw $gild $qcom  #stocks |gilead sciences $gild is s/t choppy. fpe 11, net margin 42.9%. earnings oct'26th. bullish &gt;90 to 110 by mid
2017-10-23: rt AT_USER how much is hiv cure worth alone $gild /$sgmo |$teva closed at $14.54! what an #allergan nightmare! $agn $amzn $aapl $brk $crm $cmg $dis $exel $f $googl $gild¡­ |ibd's no. 2 group tested as
2017-10-24: $gild $ahgif gilead sciences to report q3 , alternate health corp. projected $75m in revenue for the next 12 months |$gild $ahgif gilead sciences to report q3 , alternate health corp. projected $75m i
2017-10-25: #allergan #botox injector promoting #botox for depression while still unapproved in clinical trials AT_USER $agn¡­ |AT_USER if $gild can pay 12b for $kite, then why not $sgmo?  far more options with z
2017-10-26: rt AT_USER $gild said there will be an update of zuma-1 and zuma-3 at #ash17.|rt AT_USER $bmy says indirect nash markers like liver fat won¡¯t be enough. biopsy will be necessary as an endpoint in pha
2017-10-27: gilead sciences, inc. $gild issues quarterly  earnings results, beats expectations by $0.14 eps |gilead sciences, inc. $gild issues quarterly  earnings results, beats expectations by $0.14 eps |what a
2017-10-28: check this out! $tst $agn $vrx $twtr $ibm $pep $ko $hlf $gild $aapl $amzn $jnj $teva $dis $myl $mrk #allergan $brk¡­ |fyi!  $amzn $aapl $agn $myl $vrx $twtr $mrk $gild $brk $googl $iep $snap $ipxl $ms
2017-10-29: AT_USER AT_USER i do not expect $gild to pick up $blcm - gilead competitors in cart are being extremely¡­ |$gild had good earnings. m/t bullish to $110 and beyond. fpe 10s. nm 44.4%. arguably, the bes
2017-10-30: rt AT_USER today's ex of "know ur lvls" $gild:drew s/r line months ago. here is an old chart that shows it. vs where it failed |commented on  $abbv $glpg $jnj $mrk $nvo $nvs $rhhby $gild|rt AT_USER $g
2017-10-31: rt AT_USER $gild settled -7.5% to $74.96. s/t price structure is a bull flag. m/t hyper bullish &gt;90 to 110, and way beyond. nm 44.4%¡­|$gild settled -7.5% to $74.96. s/t price structure is a bull f
2017-11-01: rt AT_USER #celltherapy #dcvax potential all solid tumors $nwbo is big threat to $mrk $nvs $gild $rhhby $pfe $bmy p3 data will se¡­| review of connor alerts - excellent service for small trading accou
Answer:+Fall